sanofi buys us haemophilia treatment firm
Last Updated : GMT 05:17:37
Emiratesvoice, emirates voice
Emiratesvoice, emirates voice
Last Updated : GMT 05:17:37
Emiratesvoice, emirates voice

for $11.6 bn

Sanofi buys US haemophilia treatment firm

Emiratesvoice, emirates voice

Emiratesvoice, emirates voice Sanofi buys US haemophilia treatment firm

Sanofi
Paris - Emiratesvoice

French pharmaceutical firm Sanofi said Monday it had reached an agreement to purchase US biotech company Bioverativ, which specialises in treatments for haemophilia and rare blood disorders, for $11.6 billion.

Sanofi's chief executive Olivier Brandicourt said the acquisition "enhances its presence in specialty care and leadership in rare diseases... and creates a platform for growth in other rare blood disorders."

The purchase should also translate into a boost in profits per share beginning this year, rising to a gain of up to 5 percent in 2019, Sanofi said in a statement.

Bioverativ has latest-generation treatments for haemophilia, a disorder where blood does not clot properly to stop bleeding.

The haemophilia drugs market is "the largest market in rare diseases", worth around $10 billion per year and projected to grow by seven percent annually over the next five years, Brandicourt said in an audio conference with analysts.

He said he harboured a "strong admiration" for Bioverativ, which is a leader in the field with two drugs, Eloctate and Alprolix, already in the market and estimated overall sales of $1.2 billion in 2017.

Sanofi said it would be able to help Bioverativ with the research it has underway on the development of other haemophilia treatments, as well as for other rare diseases.

The agreement to purchase all of Bioverativ's outstanding shares for $105 each in cash represents a premium of 64 percent from the closing price on Friday, Sanofi said.

The operation is to start in February and close three months later, Brandicourt said.

But investors were not convinced, sending Sanofi's shares sharply lower on the Paris stock exchange as they wondered about the wisdom of putting so much money on the table.

The deal "looks logical, but expensive", with only modest potential to drive growth in the medium term, judged analysts at the Jefferies firm.

Furthermore, Sanofi may run into competition concerns from regulators with the takeover, they said.

The French firm said it would use funds on hand and borrow to finance the acquisition of Bioverativ.

But although pricey, the acquisition will still leave Sanofi with enough financial firepower to go after other acquisition targets, Jefferies said. One such target could be Pfizer's consumer healthcare business, they said.

The purchase of Bioverativ is the largest Sanofi has made since it acquired US biotech firm Genzyme for $20 billion in April 2011.

The French group failed in its 2016 bid to take over US cancer drugmaker Medivation which instead went to Pfizer.

Sanofi shares were 4.2 percent lower at 69.89 euros in late afternoon trading Monday, vastly underperforming the benchmark CAC 40 index in Paris which was up 0.2 percent.

Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

sanofi buys us haemophilia treatment firm sanofi buys us haemophilia treatment firm

 



Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

sanofi buys us haemophilia treatment firm sanofi buys us haemophilia treatment firm

 



GMT 09:19 2017 Thursday ,09 March

ECB set to hold course in face of mounting pressure

GMT 17:45 2016 Monday ,18 April

School Olympics embody state's future vision

GMT 13:41 2017 Wednesday ,22 November

VIRGO (August24th-September23rd)

GMT 04:22 2013 Tuesday ,29 October

Universal TV journalist dies of injuries in Somalia

GMT 10:09 2016 Tuesday ,21 June

Kuwait amends sports laws; bans might stay

GMT 02:30 2017 Thursday ,12 October

Saudi-bound PIA flight makes 'technical landing

GMT 17:00 2018 Monday ,22 January

Tourism expected to take a big leap in Malaysia

GMT 10:55 2018 Monday ,22 January

Bahrain-Indian economic ties discussed

GMT 10:28 2018 Monday ,22 January

Kindergarten Sports Day at ILOA

GMT 07:06 2018 Friday ,19 January

China economy rebounds in 2017 with 6.9% growth

GMT 07:23 2018 Thursday ,18 January

Philippine volcano 'fireworks' draw

GMT 07:28 2015 Saturday ,04 April

Djokovic, Murray set to clash in Miami final

GMT 13:04 2018 Thursday ,04 January

South African train crash toll rises to 12

GMT 11:33 2017 Sunday ,26 November

PISCES (February20th-March20th)

GMT 07:48 2015 Tuesday ,25 August

Sketch & FOUR London to launch pop-up salon

GMT 11:05 2011 Saturday ,17 December

Qalqiliya teacher unpaid for \'political reasons\'

GMT 13:09 2017 Thursday ,09 March

For US composer, understanding Trump through optics

GMT 12:35 2017 Thursday ,09 February

Is Lebanon’s crisis due to elections or to the regime

GMT 09:53 2017 Wednesday ,15 November

Saad refuses to comment on rival’s video

GMT 10:25 2017 Thursday ,23 November

PISCES (February20th-March20th)

GMT 08:14 2016 Monday ,22 August

Israel hits Hamas targets in Gaza

GMT 00:55 2017 Sunday ,11 June

Qatari media steps up its malicious

GMT 09:07 2017 Sunday ,10 December

H.E.R.,Teyana Taylor and everything else
Emiratesvoice, emirates voice
 
 Emirates Voice Facebook,emirates voice facebook  Emirates Voice Twitter,emirates voice twitter Emirates Voice Rss,emirates voice rss  Emirates Voice Youtube,emirates voice youtube  Emirates Voice Youtube,emirates voice youtube

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©

emiratesvoieen emiratesvoiceen emiratesvoiceen emiratesvoiceen
emiratesvoice emiratesvoice emiratesvoice
emiratesvoice
بناية النخيل - رأس النبع _ خلف السفارة الفرنسية _بيروت - لبنان
emiratesvoice, Emiratesvoice, Emiratesvoice